Efficacy and safety of maintenance pemetrexed in patients with advanced nonsquamous non-small cell lung cancer following pemetrexed plus cisplatin induction …

C Gridelli, F De Marinis, M Thomas, M Dediu, JL Pujol… - Lung cancer, 2014 - Elsevier
Objectives Two phase III trials of advanced NSCLC patients were compared to examine
relative efficacy and safety of differing treatment regimens. The JMDB trial investigated first …

Efficacy and safety of maintenance pemetrexed in patients with advanced nonsquamous non-small cell lung cancer following pemetrexed plus cisplatin induction …

GV Scagliotti, C Gridelli, F de Marinis… - Lung Cancer …, 2014 - europepmc.org
Objectives Two phase III trials of advanced NSCLC patients were compared to examine
relative efficacy and safety of differing treatment regimens. The JMDB trial investigated first …

[引用][C] Efficacy and safety of maintenance pemetrexed in patients with advanced nonsquamous non-small cell lung cancer following pemetrexed plus cisplatin …

GV Scagliotti, C Gridelli, F de Marinis, M Thomas… - Lung Cancer, 2014 - cir.nii.ac.jp
Efficacy and safety of maintenance pemetrexed in patients with advanced nonsquamous
non-small cell lung cancer following pemetrexed plus cisplatin induction treatment: A cross-trial …

[PDF][PDF] Questa è la versione dell'autore dell'opera

GV Scagliotti, C Gridelli, F de Marinis, M Thomas… - Lung Cancer, 2014 - core.ac.uk
Objectives Two phase III trials of advanced NSCLC patients were compared to examine
relative efficacy and safety of differing treatment regimens. The JMDB trial investigated first …

Efficacy and safety of maintenance pemetrexed in patients with advanced nonsquamous non-small cell lung cancer following pemetrexed plus cisplatin induction …

GV Scagliotti, C Gridelli, F de Marinis… - Lung cancer …, 2014 - pubmed.ncbi.nlm.nih.gov
Objectives Two phase III trials of advanced NSCLC patients were compared to examine
relative efficacy and safety of differing treatment regimens. The JMDB trial investigated first …

Efficacy and safety of maintenance pemetrexed in patients with advanced nonsquamous non-small cell lung cancer following pemetrexed plus cisplatin induction …

GV Scagliotti, C Gridelli, F de Marinis… - Lung …, 2014 - lungcancerjournal.info
Objectives Two phase III trials of advanced NSCLC patients were compared to examine
relative efficacy and safety of differing treatment regimens. The JMDB trial investigated first …

[引用][C] Efficacy and safety of maintenance pemetrexed in patients with advanced nonsquamous non-small cell lung cancer following pemetrexed plus cisplatin …

GV SCAGLIOTTI, C GRIDELLI, N CHOUAKI… - Lung …, 2014 - pascal-francis.inist.fr
Efficacy and safety of maintenance pemetrexed in patients with advanced nonsquamous
non-small cell lung cancer following pemetrexed plus cisplatin induction treatment: A cross-trial …

Efficacy and safety of maintenance pemetrexed in patients with advanced nonsquamous non-small cell lung cancer following pemetrexed plus cisplatin induction …

GV Scagliotti, C Gridelli, F de Marinis, M Thomas… - Lung Cancer, 2014 - infona.pl
Two phase III trials of advanced NSCLC patients were compared to examine relative efficacy
and safety of differing treatment regimens. The JMDB trial investigated first-line pemetrexed …

Efficacy and safety of maintenance pemetrexed in patients with advanced nonsquamous non-small cell lung cancer following pemetrexed plus cisplatin induction …

GV Scagliotti, C Gridelli, F de Marinis, M Thomas… - LUNG CANCER, 2014 - iris.unito.it
Objectives: Two phase III trials of advanced NSCLC patients were compared to examine
relative efficacy and safety of differing treatment regimens. The JMDB trial investigated first …

[引用][C] Efficacy and safety of maintenance pemetrexed in patients with advanced nonsquamous non-small cell lung cancer following pemetrexed plus cisplatin …

GV Scagliotti, C Gridelli, F de Marinis… - Lung …, 2014 - produccioncientifica.ucm.es
Objectives: Two phase III trials of advanced NSCLC patients were compared to examine
relative efficacy and safety of differing treatment regimens. The JMDB trial investigated first …